Clearmind Medicine (CMND) FCF Payout Ratio (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly FCF Payout Ratio of 1.22 for Q2 2026, down 202.44% year-over-year from 1.19 in Q2 2025, and up 72.51% quarter-over-quarter from 4.44 in Q1 2026.
Clearmind Medicine (CMND) FCF Payout Ratio (2022 - 2026) Analysis & Trends
Clearmind Medicine's FCF Payout Ratio history runs 5 years deep, the most recent figure standing at 1.22 for Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.17 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.07 |
| 10 | Clearmind Medicine | 537,435.54 | -13.06 Mn | - | -1.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1.22 |
| Jan 31, 2026 | -4.44 |
| Jul 31, 2025 | 0.90 |
| Apr 30, 2025 | 1.19 |
| Jan 31, 2025 | -4.57 |
| Jul 31, 2024 | 0.56 |
| Apr 30, 2024 | 0.82 |
| Jan 31, 2024 | -6.35 |
| Jul 31, 2023 | 1.02 |
| Jan 31, 2023 | -1.10 |
| Jul 31, 2022 | -0.11 |
| Jan 31, 2022 | -1.57 |